William A. Gray, MD

Country USA
Specialty Interventional Cardiologist
  1. Expert Thoughts on Drug-Eluting Resorbable Scaffolds on Peripheral Interventions: Dreaming or Still Caution?
  2. Percutaneous Tricuspid Valve Intervention: Multiple Options to Benefit Patient Outcomes
  3. The End of the Paclitaxel Scare: Review of the Data and Lessons Learned
  4. Evidence of DCB Treatment for Infrapopliteal Disease
  5. Leave Nothing and Suppress Restenosis: Drug-Coated Balloon
  6. Drug Eluting Stents and Bioresorable Scaffolds - What\'s the Latest News?
  7. New Design in Stent: Micromesh Technology Compared with Closed or Opened Cell Design
  8. Optimizing Outcomes with Tibial Atherectomy - What Experience and Data Have Taught Us
  9. Clinical Results and Ongoing Studies of New Drug Eluting Stent for SFA
  10. Invited Case Presentation & Focus Review: Between a Rock and No Place
  11. INSTEAD XL: Routine vs. Selective TEVAR
  12. How Shall We Change Our Practice on the Results of CREST/ICSS/ACT1?
  13. When Outcomes Matter, Design Matter
  14. Proximal Protection vs. Distal Protection in CAS
  15. ACTIVE Study: Co-Cr Balloon Expandable Stent : What Advantages over Standard Self-expandable Stent ?
  16. Drug-coated Balloon Technologies II: Clinical Outcomes and Recommended Applications
  17. Practical Aspects in FFR; When, Why and How to Use?
  18. From Puncture to Stent: Step by Step Technical Point Lessons from EVAR
  19. Evolving and Challenging Endovascular Techniques for SFA CTO
  20. Wrap Up Endovascular Outcomes of BTK Lesions and Future Directions
  21. Why CAS?
  22. Insights from EVEREST II: Clinical Utility of Transcatheter Edge-to-Edge Mitral Valve Repair
  23. Endovascular Abdominal Repair: Current Treatment and Future We Can Expect
  24. Endovascular Strategy for Aortoiliac Occlusive Disease: Patients Selection and Best Approach
  25. Achieving Optimal Clinical Results After Carotid Stenting: The PROTECT Study and Beyond...
  26. A Data-Driven Therapeutic Algorithm for Choosing Among Currently Available Tools for SFA Intervention
  27. When Is Revascularization Considered in Renal Artery Stenosis?
  28. Endovascular Repair of TAA & AAA
  29. Carotid Stenting
  30. Lower Extremity Revascularization: a Data-Driven Approach to SFA Disease